Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-18-006636)

Filing Details

Accession Number:: 0000899243-18-006636
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-07 16:22:36
Reporting Period:: 2018-03-05

Accepted Time:: 2018-03-07 16:22:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1113148	Infinity Pharmaceuticals Inc.	INFI	Pharmaceutical Preparations (2834)	330655706

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1375124	Q Adelene Perkins	C/O Infinity Pharmaceuticals, Inc. 784 Memorial Drive Cambridge MA 02139	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-03-05	5,000	$2.78	607,252	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,391	Indirect	401(K)

Footnotes

The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2017.